Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Feb 1;65(2):e41-9.
doi: 10.1097/QAI.0b013e31829ceaec.

Risk factors for delayed initiation of combination antiretroviral therapy in rural north central Nigeria

Affiliations

Risk factors for delayed initiation of combination antiretroviral therapy in rural north central Nigeria

Muktar H Aliyu et al. J Acquir Immune Defic Syndr. .

Abstract

Background: Timely initiation of combination antiretroviral therapy (ART) in eligible HIV-infected patients is associated with substantial reduction in mortality and morbidity. Nigeria has the second largest number of persons living with HIV/AIDS in the world. We examined patient characteristics, time to ART initiation, retention, and mortality at 5 rural facilities in Kwara and Niger states of Nigeria.

Methods: We analyzed program-level cohort data for HIV-infected ART-naive clients (≥15 years) enrolled from June 2009 to February 2011. We modeled the probability of ART initiation among clients meeting national ART eligibility criteria using logistic regression with splines.

Results: We enrolled 1948 ART-naive adults/adolescents into care, of whom, 1174 were ART eligible (62% female). Only 74% of the eligible patients (n = 869) initiated ART within 90 days after enrollment. The median CD4 count for eligible clients was 156 cells/μL (interquartile range: 81-257), with 67% in WHO stage III/IV disease. Adjusting for CD4 count, WHO stage, functional status, hemoglobin, body mass index, sex, age, education, marital status, employment, clinic of attendance, and month of enrollment, we found that immunosuppression [CD4 350 vs. 200, odds ratio (OR) = 2.10, 95% confidence interval (CI): 1.31 to 3.35], functional status [bedridden vs. working, OR = 4.17 (95% CI: 1.63 to 10.67)], clinic of attendance [Kuta Hospital vs. referent: OR = 5.70 (95% CI: 2.99 to 10.89)], and date of enrollment [December 2010 vs. June 2009: OR = 2.13 (95% CI: 1.19 to 3.81)] were associated with delayed ART initiation.

Conclusions: Delayed initiation of ART was associated with higher CD4 counts, lower functional status, clinic of attendance, and later dates of enrollment among ART-eligible clients. Our findings provide targets for quality improvement efforts that may help reduce attrition and improve ART uptake in similar settings.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Flowchart depicting enrollment and ART eligibility for adult patients with HIV/AIDS, Kwara and Niger states of Nigeria, 2009–2011.
Figure 2
Figure 2
Combination antiretroviral therapy initiation during the first 90 days post-enrollment, Kwara and Niger states of Nigeria, 2009–2011.

References

    1. UNGASS [Accessed 02/28/2012];UNGASS Country Progress Report: Nigeria. 2010 http://www.unaids.org/en/dataanalysis/monitoringcountryprogress/2010prog....
    1. UNAIDS . Global report: UNAIDS Report on the Global AIDS Epidemic 2010. Joint United Nations Programme on HIV/AIDS; New York: 2010. [Accessed 03/08/2012]. http://www.unaids.org/globalreport/Global_report.htm.
    1. WHO/UNAIDS/UNICEF . Progress report 2011. World Health Organization; Geneva: 2011. [Accessed 03/01/12]. Global HIV/AIDS response: Epidemic update and health services progress toward universal access. http://whqlibdoc.who.int/publications/2011/9789241502986_eng.pdf.
    1. National Agency for the Control of AIDS (NACA) Country Progress Report, Nigeria, GARPR 2012. Abuja: 2012. [Accessed 09/01/12]. Federal Republic of Nigeria Global AIDS Response. http://www.unaids.org/en/dataanalysis/knowyourresponse/countryprogressre....
    1. National Agency for the Control of AIDS (NACA) Research and New Technologies. NACA; Abuja: 2009. [Accessed 10/01/12]. National HIV/AIDS Policy Review Report. http://naca.gov.ng/index2.php?option=com_docman&task=doc_view&gid=67&Ite....

Publication types

Substances